Suardi, Nazareno
 Distribuzione geografica
Continente #
NA - Nord America 2.019
AS - Asia 1.725
EU - Europa 848
OC - Oceania 3
AF - Africa 1
Totale 4.596
Nazione #
US - Stati Uniti d'America 2.016
SG - Singapore 785
HK - Hong Kong 632
TR - Turchia 271
RU - Federazione Russa 254
IE - Irlanda 238
GB - Regno Unito 152
IT - Italia 75
DE - Germania 44
SE - Svezia 38
CN - Cina 28
FI - Finlandia 18
UA - Ucraina 10
CZ - Repubblica Ceca 9
IN - India 4
NL - Olanda 4
AU - Australia 3
CA - Canada 3
CH - Svizzera 3
FR - Francia 2
JP - Giappone 2
AZ - Azerbaigian 1
EE - Estonia 1
ID - Indonesia 1
NG - Nigeria 1
SA - Arabia Saudita 1
Totale 4.596
Città #
Singapore 640
Hong Kong 632
Princeton 484
Istanbul 271
New York 239
Dublin 238
Fairfield 150
Moscow 133
Des Moines 127
San Diego 123
Wilmington 115
London 95
Seattle 75
Ashburn 62
Woodbridge 55
Cambridge 34
Houston 34
Romola 28
Chandler 27
West Jordan 16
Helsinki 14
Norwalk 13
Munich 12
Shanghai 12
Brno 9
Hounslow 9
Kilburn 9
Chicago 7
Rome 7
Acton 6
Ann Arbor 6
Beijing 5
Chiswick 5
Jacksonville 5
New Bedfont 4
Bergamo 3
Jinan 3
Lappeenranta 3
Bologna 2
Catania 2
Cincinnati 2
Dearborn 2
Eindhoven 2
Falkenstein 2
Gandhinagar 2
Islington 2
Manchester 2
Naples 2
Niigata 2
San Francisco 2
Santa Clara 2
Secaucus 2
Toronto 2
Wandsworth 2
Zurich 2
Abuja 1
Baku 1
Boardman 1
Bolton 1
Brescia 1
Canberra 1
Cava de' Tirreni 1
Council Bluffs 1
Croydon 1
Dalmine 1
Delhi 1
Frankfurt am Main 1
Haikou 1
Hefei 1
Jakarta 1
Jeddah 1
Jiaxing 1
Krasnoyarsk 1
Los Angeles 1
Milan 1
Nanchang 1
Nanjing 1
North York 1
Nuremberg 1
Nürnberg 1
Prescot 1
Redmond 1
Redwood City 1
Rimini 1
Romford 1
Southwark 1
Sydney 1
Tallinn 1
Tappahannock 1
Torino 1
Villa di Briano 1
Westminster 1
Totale 3.781
Nome #
Salvage therapy of small volume prostate cancer nodal failures: A review of the literature 141
A proposal of a new nomogram for predicting upstaging in contemporary D'Amico low-risk prostate cancer patients 32
Port-site metastasis and atypical recurrences after robotic-assisted radical cystectomy (RARC): an updated comprehensive and systematic review of current evidences 31
A proposal of a new nomogram for predicting upstaging in contemporary D’Amico low-risk prostate cancer patients 29
A Multi-institutional Analysis of Perioperative Outcomes in 106 Men Who Underwent Radical Prostatectomy for Distant Metastatic Prostate Cancer at Presentation 28
Accuracy of life tables in predicting overall survival in patients after radical prostatectomy 26
Assessment of HER2 protein overexpression and gene amplification in renal collecting duct carcinoma: Therapeutic implication 26
A nomogram for staging of exclusive nonobturator lymph node metastases in men with localized prostate cancer 26
The European Association of Urology Robotic Urology Section (ERUS) survey of robot-assisted radical prostatectomy (RARP) 25
A Nomogram Predicting Prostate Cancer-Specific Mortality after Radical Prostatectomy 25
The effect of surgical volume, age and comorbidities on 30-day mortality after radical prostatectomy: a population-based analysis of 9208 consecutive cases 24
Minimally invasive strategies for the treatment of prostate cancer recurrence after radiation therapy: a systematic review 23
Age at diagnosis is a determinant factor of renal cell carcinoma-specific survival in patients treated with nephrectomy 23
A Detailed Analysis of the Association Between Postoperative Phosphodiesterase Type 5 Inhibitor Use and the Risk of Biochemical Recurrence After Radical Prostatectomy 23
Adjuvant chemotherapy for bladder cancer does not alter cancer-specific survival after cystectomy in a matched case-control study 23
A critical analysis of laser prostatectomy in the management of benign prostatic hyperplasia 22
THE RATE OF SECONDARY MALIGNANCIES AFTER RADICAL PROSTATECTOMY VERSUS EXTERNAL BEAM RADIATION THERAPY FOR LOCALIZED PROSTATE CANCER: A POPULATION-BASED STUDY ON 17,845 PATIENTS 22
A nomogram is more accurate than a regression tree in predicting lymph node invasion in prostate cancer 22
A nomogram predicting long-term biochemical recurrence after radical prostatectomy 22
Acceptance of and discontinuation rate from erectile dysfunction oral treatment in patients following bilateral nerve-sparing radical prostatectomy 21
Identifying the Optimal Candidate for Salvage Lymph Node Dissection for Nodal Recurrence of Prostate Cancer: Results from a Large, Multi-institutional Analysis 21
The Number of Cores at First Biopsy May Suggest the Need for a Confirmatory Biopsy in Patients Eligible for Active Surveillance-Implication for Clinical Decision Making in the Real-life Setting 21
Incidence and Predictors of 30-Day Readmission After Robot-Assisted Radical Prostatectomy 21
Age-adjusted validation of the most stringent criteria for active surveillance in low-risk prostate cancer patients 21
Assessing the risk of lymph node invasion in patients with intermediate risk prostate cancer treated with extended pelvic lymph node dissection. A novel prediction tool 21
Robotic laparoendoscopic single-site radical prostatectomy (R-LESS-RP) with daVinci Single-Site® platform. Concept and evolution of the technique following an IDEAL phase 1 21
Serum Sex Steroids Depict a Nonlinear U-Shaped Association with High-Risk Prostate Cancer at Radical Prostatectomy 21
Impact of chronic prostatitis-like symptoms on the quality of life in a large group of men 20
Robot-assisted Salvage Lymph Node Dissection for Clinically Recurrent Prostate Cancer 20
Perioperative and Oncologic Outcomes of Nephrectomy and Caval Thrombectomy Using Extracorporeal Circulation and Deep Hypothermic Circulatory Arrest for Renal Cell Carcinoma Invading the Supradiaphragmatic Inferior Vena Cava and/or Right Atrium 20
Current Standard Technique for Modern Flexible Ureteroscopy: Tips and Tricks 20
Mortality at 120 days after prostatic biopsy: A population-based study of 22,175 men 20
Technologies for image-guided surgery for managing lymphatic metastases in prostate cancer 20
Unilateral positive biopsies in low risk prostate cancer patients diagnosed with extended transrectal ultrasound-guided biopsy schemes do not predict unilateral prostate cancer at radical prostatectomy 20
Pre-Treatment Biomarker Levels Improve the Accuracy of Post-Prostatectomy Nomogram for Prediction of Biochemical Recurrence 20
Rationale for local treatment in the management of metastatic prostate cancer 20
A nomogram predicting the cancer-specific mortality in patients eligible for radical cystectomy evaluating clinical data and neoadjuvant cisplatinum-based chemotherapy 19
New surgical approaches for clinically high-risk or metastatic prostate cancer 19
Preoperative erectile function is the only predictor of the use of a high number of phosphodiesterase type-5 inhibitors after bilateral nerve-sparing radical prostatectomy 19
Prevention and Management of Postprostatectomy Erectile Dysfunction 19
Staging lymphadenectomy in renal cell carcinoma must be extended: a sensitivity curve analysis 19
Preoperative sex steroids are significant predictors of early biochemical recurrence after radical prostatectomy 19
Baseline prevalence of erectile dysfunction in a prostate cancer screening population 19
Poor overall survival in septa- and octogenarian patients after radical prostatectomy and radiotherapy for prostate cancer: A population-based study of 6183 men 19
Higher-than-expected Severe (Grade 3-4) Late Urinary Toxicity After Postprostatectomy Hypofractionated Radiotherapy: A Single-institution Analysis of 1176 Patients 19
Cytoreductive Radical Prostatectomy in Men with Prostate Cancer and Skeletal Metastases 19
When to perform preoperative chest computed tomography for renal cancer staging 19
The Selection of Patients for Active Surveillance: Could It Be Perfect? 19
Long-term Outcomes of Salvage Lymph Node Dissection for Clinically Recurrent Prostate Cancer: Results of a Single-institution Series with a Minimum Follow-up of 5 Years 19
Underestimation of positron emission tomography/computerized tomography in assessing tumor burden in prostate cancer nodal recurrence: Head-to-head comparison of 68Ga-PSMA and 11C-choline in a large, multi-institutional series of extended salvage lymph node dissections 19
When to perform lymph node dissection in patients with renal cell carcinoma: a novel approach to the preoperative assessment of risk of lymph node invasion at surgery and of lymph node progression during follow-up 19
Assessing the minimum number of lymph nodes needed at radical cystectomy in patients with bladder cancer 19
Tumour architecture is an independent predictor of outcomes after nephroureterectomy: a multi-institutional analysis of 1363 patients 19
A novel tool to assess the risk of urinary incontinence after nerve-sparing radical prostatectomy 19
Two Positive Nodes Represent a Significant Cut-off Value for Cancer Specific Survival in Patients with Node Positive Prostate Cancer. A New Proposal Based on a Two-Institution Experience on 703 Consecutive N plus Patients Treated with Radical Prostatectomy, Extended Pelvic Lymph Node Dissection and Adjuvant Therapy 19
Complications and other surgical outcomes associated with extended pelvic lymphadenectomy in men with localized prostate cancer 19
Presence of positive surgical margin in patients with organ-confined prostate cancer equals to extracapsular extension negative surgical margin. A plea for TNM staging system reclassification 19
The CDK Inhibitor Dinaciclib Improves Cisplatin Response in Nonseminomatous Testicular Cancer: A Preclinical Study 18
The Role of Prostate-specific Antigen Persistence After Radical Prostatectomy for the Prediction of Clinical Progression and Cancer-specific Mortality in Node-positive Prostate Cancer Patients 18
Neoadjuvant Short-term Intensive Intravesical Mitomycin C Regimen Compared with Weekly Schedule for Low-grade Recurrent Non-muscle-invasive Bladder Cancer: Preliminary Results of a Randomised Phase 2 Study (vol 62, pg 797, 2012) 18
Are Infertile Men Less Healthy than Fertile Men? Results of a Prospective Case-Control Survey 18
What Is the Definition of a Satisfactory Erectile Function After Bilateral Nerve Sparing Radical Prostatectomy? 18
Pregnant woman presenting with a gross retroperitoneal mass: Surgical treatment with caval replacement 18
Impact of Lymph Node Dissection on Cancer Specific Survival in Patients With Upper Tract Urothelial Carcinoma Treated With Radical Nephroureterectomy 18
Robotic-assisted laparoscopic pyeloplasty with the use of the Contour (TM) stent: description of the technique and analysis of outcomes after the first 30 cases 18
Assessing the most accurate formula to predict the risk of lymph node metastases from prostate cancer in contemporary patients treated with radical prostatectomy and extended pelvic lymph node dissection 18
Assessing the Impact of Surgeon Experience on Urinary Continence Recovery after Robot-Assisted Radical Prostatectomy: Results of Four High-Volume Surgeons 18
Impact of multiparametric MRI and MRI-targeted biopsy on pre-therapeutic risk assessment in prostate cancer patients candidate for radical prostatectomy 18
Non-surgically related causes of erectile dysfunction after bilateral nerve-sparing radical prostatectomy 18
Reply from Authors re: Michael W. Kattan. Classification and Regression Trees Versus Nomograms: A Bone Scan Positivity Example. Eur Urol 2010;57:559-60 18
Re: Prasanna Sooriakumaran, Abhishek Srivastava, Shahrokh F. Shariat, et al. A Multinational, Multi-institutional Study Comparing Positive Surgical Margin Rates Among 22 393 Open, Laparoscopic, and Robot-assisted Radical Prostatectomy Patients. Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2013.11.018 18
Preoperative circulating sex hormones are not predictors of positive surgical margins at open radical prostatectomy 18
External Validation of the European Association of Urology Recommendations for Pelvic Lymph Node Dissection in Patients Treated with Robot-Assisted Radical Prostatectomy 18
The Role of Prostate-specific Antigen Persistence after Radical Prostatectomy for the Prediction of Clinical Progression and Cancer-specific Mortality in Node-positive Prostate Cancer Patients 18
A nomogram predicting metastatic progression after radical prostatectomy 18
Circulating sex steroids and prostate cancer: introducing the time-dependency theory 18
A Preoperative Prognostic Model for Patients Treated with Nephrectomy for Renal Cell Carcinoma 18
Re: Giuseppe Simone, Umberto Anceschi, Gabriele Tuderti, et al. Robot-assisted Partial Adrenalectomy for the Treatment of Conn's Syndrome: Surgical Technique, and Perioperative and Functional Outcomes. Eur Urol 2019;75:811–6 18
Evaluation of positive surgical margins in patients undergoing robot-assisted and open radical prostatectomy according to preoperative risk groups 18
Impact of Postoperative Radiotherapy in Men with Persistently Elevated Prostate-specific Antigen After Radical Prostatectomy for Prostate Cancer: A Long-term Survival Analysis 18
Rationale for local treatment in the management of metastatic prostate cancer 18
‘En Bloc’ HoLEP with early apical release in men with benign prostatic hyperplasia 18
Long-Term Follow-up of Patients with Prostate Cancer and Nodal Metastases Treated by Pelvic Lymphadenectomy and Radical Prostatectomy: The Positive Impact of Adjuvant Radiotherapy 18
Prediction of delayed graft function after renal transplantation 18
EXTERNAL VALIDATION OF THE UPDATED PARTIN TABLES IN A COHORT OF FRENCH AND ITALIAN MEN 18
Conditional Survival Predictions After Nephrectomy for Renal Cell Carcinoma 18
Impact of Preoperative Thrombocytosis on Pathological Outcomes and Survival in Patients Treated with Radical Cystectomy for Bladder Carcinoma 18
Neoadjuvant sutent induction therapy may effectively down-stage renal cell carcinoma atrial thrombi 18
Long-term evaluation of survival, continence and potency (SCP) outcomes after robot-assisted radical prostatectomy (RARP) 18
Identifying candidates for super-extended staging pelvic lymph node dissection among patients with high-risk prostate cancer 18
Currently Used Criteria for Active Surveillance in Men With Low-risk Prostate Cancer An Analysis of Pathologic Features 18
The New Prostate Cancer Grading System Does Not Improve Prediction of Clinical Recurrence After Radical Prostatectomy: Results of a Large, Two-Center Validation Study 18
There is no way to identify patients who will harbor small volume, unilateral prostate cancer at final pathology. Implications for focal therapies 18
Health-insurance status is a determinant of the stage at presentation and of cancer control in European men treated with radical prostatectomy for clinically localized prostate cancer 17
Predicting the risk of bone metastasis in prostate cancer 17
What is the optimal definition of misclassification in patients with very low-risk prostate cancer eligible for active surveillance? Results from a multi-institutional series 17
Robotic surgery in patients with achondroplastic dwarfism: evaluation of risks and issues in an anatomical challenging bilateral partial nephrectomy 17
STAMPEDE trial and patients with non-metastatic prostate cancer 17
The Number of Cores at First Biopsy May Suggest the Need for a Confirmatory Biopsy in Patients Eligible for Active Surveillance-Implication for Clinical Decision Making in the Real-life Setting REPLY 17
Radical prostatectomy represents an effective treatment in patients with specimen-confined high pathological Gleason score prostate cancer 17
Totale 2.107
Categoria #
all - tutte 91.707
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 91.707


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202020 0 0 0 0 0 0 6 6 3 3 0 2
2020/202117 0 3 0 2 0 4 0 3 1 3 1 0
2021/20221.305 1 3 0 0 0 560 38 70 60 195 131 247
2022/2023668 242 1 0 3 13 258 0 11 99 5 22 14
2023/20241.371 16 9 23 25 19 244 75 6 593 22 12 327
2024/20251.459 9 4 43 392 654 316 41 0 0 0 0 0
Totale 4.908